Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endo International Plc (ENDP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Endo International Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1593034.
Total stock buying since 2014: $3,034,027.
Total stock sales since 2014: $33,112,951.
Total stock option exercises since 2014: $11,703,402.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 0 | $0 | 342,752 | $0 |
| 2021 | 0 | $0 | 26,323 | $227,964 | 1,033,806 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 726,483 | $0 |
| 2019 | 0 | $0 | 89,951 | $362,307 | 0 | $0 |
| 2018 | 0 | $0 | 46,074 | $656,976 | 0 | $0 |
| 2017 | 38,300 | $304,116 | 14,459 | $120,640 | 0 | $0 |
| 2016 | 41,875 | $783,487 | 27,652 | $825,036 | 163,559 | $281,855 |
| 2015 | 25,097 | $1,468,971 | 201,833 | $17,848,586 | 218,417 | $6,278,017 |
| 2014 | 7,200 | $477,453 | 181,797 | $13,071,442 | 206,364 | $5,143,530 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-03 | 0 | $0 | 0 | $0 | 342,752 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 1,033,806 | $0 |
| 2021-03 | 0 | $0 | 26,323 | $227,964 | 0 | $0 |
| 2020-02 | 0 | $0 | 0 | $0 | 726,483 | $0 |
| 2019-09 | 0 | $0 | 55,000 | $224,950 | 0 | $0 |
| 2019-06 | 0 | $0 | 34,951 | $137,357 | 0 | $0 |
| 2018-12 | 0 | $0 | 10,000 | $114,100 | 0 | $0 |
| 2018-11 | 0 | $0 | 10,000 | $128,300 | 0 | $0 |
| 2018-08 | 0 | $0 | 26,074 | $414,576 | 0 | $0 |
| 2017-11 | 0 | $0 | 9,134 | $63,024 | 0 | $0 |
| 2017-08 | 36,000 | $279,460 | 0 | $0 | 0 | $0 |
| 2017-03 | 2,300 | $24,656 | 5,325 | $57,616 | 0 | $0 |
| 2016-11 | 0 | $0 | 14,000 | $249,060 | 0 | $0 |
| 2016-05 | 36,000 | $549,500 | 0 | $0 | 0 | $0 |
| 2016-03 | 5,875 | $233,987 | 13,652 | $575,976 | 163,559 | $281,855 |
| 2015-11 | 22,597 | $1,266,221 | 8,000 | $443,840 | 30,384 | $1,027,851 |
| 2015-06 | 2,500 | $202,750 | 0 | $0 | 0 | $0 |
| 2015-04 | 0 | $0 | 105,562 | $9,701,147 | 105,562 | $3,137,237 |
| 2015-03 | 0 | $0 | 88,271 | $7,703,599 | 82,471 | $2,112,929 |
| 2014-11 | 3,700 | $247,678 | 0 | $0 | 0 | $0 |
| 2014-10 | 0 | $0 | 0 | $0 | 4,567 | $136,279 |
| 2014-08 | 3,500 | $229,775 | 0 | $0 | 20,000 | $441,200 |
| 2014-06 | 0 | $0 | 6,764 | $465,566 | 6,764 | $166,597 |
| 2014-05 | 0 | $0 | 175,033 | $12,605,876 | 175,033 | $4,399,454 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-30 | Bradley Mark T. (EVP, Chief Financial Officer) | Option Ex | 37,540 | .00 | 0 |
| 2022-03-30 | Barry Patrick A (EVP & Pres,Global Comm Ops) | Option Ex | 59,298 | .00 | 0 |
| 2022-03-30 | Coleman Blaise (President, CEO) | Option Ex | 125,573 | .00 | 0 |
| 2022-03-30 | Maletta Matthew Joseph (EVP, CLO & Company Secretary) | Option Ex | 120,341 | .00 | 0 |
| 2021-04-06 | Bradley Mark T. (EVP, Chief Financial Officer) | Option Ex | 46,409 | .00 | 0 |
| 2021-04-06 | Boyle Jack D. (SVP, Controller) | Option Ex | 22,962 | .00 | 0 |
| 2021-04-06 | Barry Patrick A (EVP & Pres,Global Comm Ops) | Option Ex | 53,039 | .00 | 0 |
| 2021-04-06 | Coleman Blaise (President, CEO) | Option Ex | 121,548 | .00 | 0 |
| 2021-04-06 | Maletta Matthew Joseph (EVP, CLO & Company Secretary) | Option Ex | 121,548 | .00 | 0 |
| 2021-04-06 | Campanelli Paul | Option Ex | 668,300 | .00 | 0 |
| 2021-03-15 | Cooke Shane | Sale | 17,290 | 8.65 | 149,558 |
| 2021-03-15 | Montague William P | Sale | 9,033 | 8.68 | 78,406 |
| 2020-02-25 | Boyle Jack D. (SVP, Controller) | Option Ex | 8,385 | .00 | 0 |
| 2020-02-25 | Garella Rahul (EVP, Intl Pharmaceuticals) | Option Ex | 20,340 | .00 | 0 |
| 2020-02-25 | Barry Patrick A (EVP & Chief Commercial Officer) | Option Ex | 27,603 | .00 | 0 |
| 2020-02-25 | Coleman Blaise (EVP, Chief Financial Officer) | Option Ex | 63,564 | .00 | 0 |
| 2020-02-25 | Maletta Matthew Joseph (EVP, Chief Legal Officer) | Option Ex | 61,748 | .00 | 0 |
| 2020-02-25 | Coughlin Terrance J (EVP, Chief Operating Officer) | Option Ex | 108,968 | .00 | 0 |
| 2020-02-25 | Campanelli Paul (President, CEO) | Option Ex | 435,875 | .00 | 0 |
| 2019-09-16 | Kimmel Roger H | Sale | 55,000 | 4.09 | 224,950 |
| 2019-06-17 | Kimmel Roger H | Sale | 34,951 | 3.93 | 137,357 |
| 2018-12-10 | Montague William P (Director) | Sale | 10,000 | 11.41 | 114,100 |
| 2018-11-15 | Hutson Nancy J (Director) | Sale | 10,000 | 12.83 | 128,300 |
| 2018-08-14 | Kimmel Roger H (Director) | Sale | 26,074 | 15.90 | 414,576 |
| 2017-11-15 | Kimmel Roger H (Director) | Sale | 9,134 | 6.90 | 63,024 |
| 2017-08-15 | Coleman Blaise (EVP, Chief Financial Officer) | Buy | 6,500 | 7.89 | 51,285 |
| 2017-08-15 | Maletta Matthew Joseph (EVP, Chief Legal Officer) | Buy | 3,000 | 8.02 | 24,060 |
| 2017-08-14 | Campanelli Paul (President, CEO) | Buy | 6,500 | 7.71 | 50,115 |
| 2017-08-10 | Coughlin Terrance J (EVP, Chief Operating Officer) | Buy | 20,000 | 7.70 | 154,000 |
| 2017-03-16 | Campanelli Paul (President, CEO) | Buy | 2,300 | 10.72 | 24,656 |
| 2017-03-09 | Hutson Nancy J (Director) | Sale | 5,325 | 10.82 | 57,616 |
| 2016-11-15 | Kimmel Roger H (Director) | Sale | 14,000 | 17.79 | 249,060 |
| 2016-05-11 | Higgins Arthur J (Director) | Buy | 5,000 | 13.80 | 69,000 |
| 2016-05-10 | Campanelli Paul (Group President, Generics) | Buy | 13,000 | 15.53 | 201,890 |
| 2016-05-10 | Higgins Arthur J (Director) | Buy | 11,000 | 15.42 | 169,620 |
| 2016-05-10 | Kimmel Roger H (Director) | Buy | 7,000 | 15.57 | 108,990 |
| 2016-03-21 | De Silva Rajiv (President & CEO) | Option Ex | 143,818 | .00 | 0 |
| 2016-03-17 | Spengler William (Director) | Buy | 1,000 | 29.20 | 29,200 |
| 2016-03-16 | Spengler William (Director) | Buy | 1,000 | 35.24 | 35,240 |
| 2016-03-14 | Kimmel Roger H (Director) | Buy | 1,125 | 41.94 | 47,182 |
| 2016-03-11 | Kimmel Roger H (Director) | Option Ex | 6,764 | 41.67 | 281,855 |
| 2016-03-07 | Maletta Matthew Joseph (Exec. V.P.,Chief Legal Officer) | Buy | 500 | 44.48 | 22,240 |
| 2016-03-07 | De Silva Rajiv (President & CEO) | Buy | 2,250 | 44.50 | 100,125 |
| 2016-03-02 | Lortie Brian (President Branded Pharma) | Option Ex | 12,977 | .00 | 0 |
| 2016-03-01 | Smith Jill D. (Director) | Sale | 3,413 | 42.19 | 143,994 |
| 2016-03-01 | Hutson Nancy J (Director) | Sale | 3,413 | 42.19 | 143,994 |
| 2016-03-01 | Spengler William (Director) | Sale | 3,413 | 42.19 | 143,994 |
| 2016-03-01 | Hyatt Michael (Director) | Sale | 3,413 | 42.19 | 143,994 |
| 2015-11-16 | Kimmel Roger H (Director) | Buy | 841 | 57.00 | 47,937 |
| 2015-11-12 | Cooke Shane (Director) | Buy | 4,000 | 57.13 | 228,520 |
| 2015-11-11 | Maletta Matthew Joseph (Exec. V.P.,Chief Legal Officer) | Buy | 500 | 56.19 | 28,095 |
| 2015-11-11 | Lortie Brian (President Branded Pharma) | Buy | 700 | 56.47 | 39,529 |
| 2015-11-11 | Hall Susan (EVP, CSO, Global Head of R&D) | Buy | 1,000 | 55.35 | 55,350 |
| 2015-11-11 | Upadhyay Suketu (EVP, Chief Financial Officer) | Buy | 4,450 | 55.99 | 249,177 |
| 2015-11-11 | De Silva Rajiv (President & CEO) | Buy | 9,006 | 55.52 | 500,013 |
| 2015-11-11 | Campanelli Paul (President, Par Pharmaceutical) | Buy | 2,100 | 56.00 | 117,600 |
| 2015-11-11 | Hyatt Michael (Director) | Sale | 8,000 | 55.48 | 443,840 |
| 2015-11-11 | Hyatt Michael (Director) | Option Ex | 10,000 | 31.43 | 314,300 |
| 2015-11-11 | Kimmel Roger H (Director) | Option Ex | 10,384 | 16.80 | 174,451 |
| 2015-11-05 | Kimmel Roger H (Director) | Option Ex | 10,000 | 53.91 | 539,100 |
| 2015-06-16 | Higgins Arthur J (Director) | Buy | 2,500 | 81.10 | 202,750 |
| 2015-04-08 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Sale | 105,059 | 91.90 | 9,654,922 |
| 2015-04-08 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Option Ex | 105,059 | 29.76 | 3,126,871 |
| 2015-04-07 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Sale | 503 | 91.90 | 46,225 |
| 2015-04-07 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Option Ex | 503 | 20.61 | 10,366 |
| 2015-03-09 | Farhat Camille (President, AMS, Inc.) | Sale | 40,438 | 87.02 | 3,518,914 |
| 2015-03-09 | Farhat Camille (President, AMS, Inc.) | Option Ex | 40,438 | 31.54 | 1,275,212 |
| 2015-03-05 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Sale | 42,033 | 87.78 | 3,689,656 |
| 2015-03-05 | Manogue Caroline B (Exec. V.P.,Chief Legal Officer) | Option Ex | 42,033 | 19.93 | 837,717 |
| 2015-03-04 | Lortie Brian (President Branded Pharma) | Sale | 5,800 | 85.35 | 495,029 |
| 2014-11-14 | Upadhyay Suketu (EVP, Chief Financial Officer) | Buy | 3,700 | 66.94 | 247,678 |
| 2014-10-14 | Kimmel Roger H (Director) | Option Ex | 4,567 | 29.84 | 136,279 |
| 2014-08-19 | Hyatt Michael (Director) | Option Ex | 10,000 | 22.06 | 220,600 |
| 2014-08-11 | Kimmel Roger H (Director) | Option Ex | 10,000 | 22.06 | 220,600 |
| 2014-08-05 | Higgins Arthur J (Director) | Buy | 3,500 | 65.65 | 229,775 |
| 2014-06-09 | Delucca John (Director) | Sale | 6,764 | 68.83 | 465,566 |
| 2014-06-09 | Delucca John (Director) | Option Ex | 6,764 | 24.63 | 166,597 |
| 2014-05-29 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 175,033 | 72.02 | 12,605,876 |
| 2014-05-29 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 175,033 | 25.14 | 4,399,454 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENDP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endo International Plc (symbol ENDP, CIK number 1593034) see the Securities and Exchange Commission (SEC) website.